hsa-mir-4705: Hsa-mir-4705 is a microRNA that has been implicated in the regulation of gastric cancer progression [PMC8798177]. The abnormal expression of hsa-mir-4705, along with other molecules such as hsa_circ_0067934 and BMPR1B, can disrupt the signaling pathways involved in stem cell pluripotency and the Hippo pathway, leading to the development and progression of gastric cancer [PMC8798177]. However, further experiments are needed to fully understand the role of hsa-mir-4705 in gastric cancer [PMC8798177]. In a study, hsa_circ_0067934 was knocked down in normal gastric cell lines to investigate its impact on the expression of hsa-mir-4705 and BMPR1B [PMC8798177]. BMPR1B is a transmembrane receptor that is targeted by hsa-mir-4705 and belongs to the bone morphogenetic protein receptor family [PMC8798177]. Hsa-mir-4705 was initially discovered in breast cancer through next-generation sequencing [PMC8798177]. The dysregulation of hsa-mir-4705 has been found to suppress the expression of BMPR1B in gastric cancer, suggesting its role as a tumor suppressor [PMC8798177]. Additionally, several miRNAs have been identified as common targets shared by different modules or networks involving hsa-mir-4705, such as miR-421, miR-1299, miR-3167, miR-148a-5p, miR106b-5p, miR20a-5p, and miR34a3p [PMC9441041] [PMC9650411] [PMC6557814].